Evoke Pharma, Inc. is a specialty pharmaceutical company based in Solana Beach, California, focused on addressing unmet medical needs in gastroenterological diseases. The company’s flagship product, Gimoti, represents a novel nasal formulation of metoclopramide designed to effectively treat gastroparesis in diabetic patients, highlighting Evoke's commitment to innovative therapeutic solutions. With a strategic emphasis on expanding its portfolio in the gastrointestinal sector, Evoke is poised for growth and aims to enhance patient outcomes through its targeted drug development initiatives. Given the increasing demand for specialized treatments, Evoke’s unique position in the market reflects potential for significant impact and returns in the specialty pharmaceutical landscape.